|
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults Clinical research trials and HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults. HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults clinical trial. Test subjects typically receive the most expert healthcare available for their HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults  HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
For Condition: HIV Seronegativity,HIV Infections
Status: No longer recruiting
Sponsor(s): Walter Reed Army Institute of Research (WRAIR) ,
Synopsis: The purpose of this study is to determine the best way to administer the candidate HIV vaccine, ALVAC HIV-1 (vCP205).
Details: Healthy adult volunteers are assigned randomly to either a vaccine or placebo group. Injections are received either intramuscularly, intradermally, or by delivery under the skin of the volunteer's own white blood cells which have had dendritic cell reinfusion. Volunteers are vaccinated at 0, 1, 3, and 6 month time points. Volunteers are closely monitored for 1 hour after vaccination and keep a diary of symptoms for 1 week post-immunization. Volunteers undergo leukopheresis at the start of the study and after the last vaccination at Walter Reed Army Medical Center. Volunteers receive compensation benefits.
Eligibility:
Study Type: Interventional, Prevention
Minimum Age/Maximum Age: 18 Years/55 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Volunteers may be eligible for this study if they: - Are legal US residents. - Are healthy adults from 18 to 55 years of age. Exclusion Criteria Volunteers will not be eligible for this study if they: - Are HIV-positive. - Are at highest risk for HIV infection. - Are pregnant or breast-feeding. - Are allergic to eggs or neomycin. - Use certain prescription medications.
Total Enrollment: 36
Location and Contact Information:
Overall Study Official:
MaryMarovich, Principal Investigator,
Walter Reed Army Institute of Research (WRAIR)
Rockville, Maryland, 20850
United States
Additional Information:
Study ID Numbers: B011; RV 138
Study Start Date:
Record last reviewed: March 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013572
Other Hiv Infections Studies:
1. HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
2. HIV-1 Vaccine Test in Uninfected Adult Volunteers
3. A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
4. Carotid Artery Thickness in HIV Infected and Uninfected Adults
5. Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
Related Studies:
Other HIV Infections Clinical Trials
Other Maryland Clinical Trials
Other Rockville Clinical Trials
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
|
|
|
|
|
|
|
|
